These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors]. Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319 [TBL] [Abstract][Full Text] [Related]
25. Expression of underglycosylated MUC1 antigen in cancerous and adjacent normal breast tissues. Ghosh SK; Pantazopoulos P; Medarova Z; Moore A Clin Breast Cancer; 2013 Apr; 13(2):109-18. PubMed ID: 23122537 [TBL] [Abstract][Full Text] [Related]
26. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma. Matsukita S; Nomoto M; Kitajima S; Tanaka S; Goto M; Irimura T; Kim YS; Sato E; Yonezawa S Histopathology; 2003 Jan; 42(1):26-36. PubMed ID: 12493022 [TBL] [Abstract][Full Text] [Related]
27. Data-Driven Prioritization and Review of Targets for Molecular-Based Theranostic Approaches in Pancreatic Cancer. Koller M; Hartmans E; de Groot DJA; Zhao XJ; van Dam GM; Nagengast WB; Fehrmann RSN J Nucl Med; 2017 Dec; 58(12):1899-1903. PubMed ID: 29051346 [TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical expression of mucin antigens in gallbladder adenocarcinoma: MUC1-positive and MUC2-negative expression Is associated with vessel invasion and shortened survival. Hiraki T; Yamada S; Higashi M; Hatanaka K; Yokoyama S; Kitazono I; Goto Y; Kirishima M; Batra SK; Yonezawa S; Tanimoto A Histol Histopathol; 2017 Jun; 32(6):585-596. PubMed ID: 27672051 [TBL] [Abstract][Full Text] [Related]
29. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms. Yonezawa S; Nakamura A; Horinouchi M; Sato E J Hepatobiliary Pancreat Surg; 2002; 9(3):328-41. PubMed ID: 12353144 [TBL] [Abstract][Full Text] [Related]
30. Increased expression of MUC1 in advanced pancreatic cancer. Hinoda Y; Ikematsu Y; Horinochi M; Sato S; Yamamoto K; Nakano T; Fukui M; Suehiro Y; Hamanaka Y; Nishikawa Y; Kida H; Waki S; Oka M; Imai K; Yonezawa S J Gastroenterol; 2003; 38(12):1162-6. PubMed ID: 14714254 [TBL] [Abstract][Full Text] [Related]
31. Pancreatic ductal adenocarcinoma mice lacking mucin 1 have a profound defect in tumor growth and metastasis. Besmer DM; Curry JM; Roy LD; Tinder TL; Sahraei M; Schettini J; Hwang SI; Lee YY; Gendler SJ; Mukherjee P Cancer Res; 2011 Jul; 71(13):4432-42. PubMed ID: 21558393 [TBL] [Abstract][Full Text] [Related]
32. Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients. Servais EL; Colovos C; Rodriguez L; Bograd AJ; Nitadori J; Sima C; Rusch VW; Sadelain M; Adusumilli PS Clin Cancer Res; 2012 May; 18(9):2478-89. PubMed ID: 22371455 [TBL] [Abstract][Full Text] [Related]
33. Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma. Tessier-Cloutier B; Kalloger SE; Al-Kandari M; Milne K; Gao D; Nelson BH; Renouf DJ; Sheffield BS; Schaeffer DF BMC Cancer; 2017 Sep; 17(1):618. PubMed ID: 28870260 [TBL] [Abstract][Full Text] [Related]
34. Assessment of the clinicopathological relevance of mesothelin level in plasma, peritoneal fluid, and tumor tissue of epithelial ovarian cancer patients. Okła K; Surówka J; Frąszczak K; Czerwonka A; Kaławaj K; Wawruszak A; Kotarski J; Wertel I Tumour Biol; 2018 Oct; 40(10):1010428318804937. PubMed ID: 30319054 [TBL] [Abstract][Full Text] [Related]
35. High level of FOXC1 expression is associated with poor prognosis in pancreatic ductal adenocarcinoma. Wang L; Gu F; Liu CY; Wang RJ; Li J; Xu JY Tumour Biol; 2013 Apr; 34(2):853-8. PubMed ID: 23242609 [TBL] [Abstract][Full Text] [Related]
36. PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma. Gold DV; Karanjawala Z; Modrak DE; Goldenberg DM; Hruban RH Clin Cancer Res; 2007 Dec; 13(24):7380-7. PubMed ID: 18094420 [TBL] [Abstract][Full Text] [Related]
37. Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas. Adsay NV; Merati K; Nassar H; Shia J; Sarkar F; Pierson CR; Cheng JD; Visscher DW; Hruban RH; Klimstra DS Am J Surg Pathol; 2003 May; 27(5):571-8. PubMed ID: 12717243 [TBL] [Abstract][Full Text] [Related]
38. Structural analysis of the cancer-specific promoter in mesothelin and in other genes overexpressed in cancers. Ren YR; Patel K; Paun BC; Kern SE J Biol Chem; 2011 Apr; 286(14):11960-9. PubMed ID: 21288909 [TBL] [Abstract][Full Text] [Related]
39. Molecular profile of apomucin and p53 protein as predictors of malignancy in intraductal papillary mucinous neoplasms of the pancreas. Mizumoto M; Honjo G; Kobashi Y; Awane M; Matsusue S Hepatogastroenterology; 2011; 58(110-111):1791-5. PubMed ID: 22086702 [TBL] [Abstract][Full Text] [Related]